Gene · 4060
NIH grants2,305
NIH grants whose papers are about the gene, through NIH's grant-paper links.
81 to 100 of 2,305
Download this page as JSON| Grant | Title | LUM papers | Newest fiscal year |
|---|---|---|---|
| R01EB017753 | Pathological consequences of altered tissue mechanics in fibrosis | 2 | 2025 |
| R01EY003611 | Optically Induced Anisometropias | 2 | 2025 |
| R01EY025377 | The Role of MicroRNAs in Normal and Diseased Corneal Epithelial Homeostasis | 2 | 2025 |
| R01EY028949 | A Novel Pathogenic Pathway for Diabetic Keratopathy | 2 | 2025 |
| R01EY029289 | Hyaluronan in the limbal stem cell niche: from regulation of stem cell fate to translational applications | 2 | 2025 |
| R01HL127349 | Genomic Analysis of Tissue and Cellular Heterogeneity in IPF | 2 | 2025 |
| R01HL148239 | Multimodal genetic regulatory architecture of coronary artery disease | 2 | 2025 |
| R01HL158525 | Molecular mechanisms of vascular calcification and their connection to coronary disease risk | 2 | 2025 |
| R01HL164577 | Functional genomics investigation of pleiotropic vascular disease loci | 2 | 2025 |
| R01HL171045 | Gene regulatory networks controlling smooth muscle phenotype and vasculardisease risk | 2 | 2025 |
| R01NS047726 | Mechanisms of resealing and rebuilding in muscle repair | 2 | 2025 |
| R35GM118103 | Recognition of Cellular Targets by single and double-stranded nucleic acids | 2 | 2025 |
| R35GM128915 | Molecular Principles Governing Mitochondrial and Peroxisomal Remodeling as Drivers of Cell Fate and Identity | 2 | 2025 |
| R35GM142695 | Statistical and Machine Learning Methods to Address Biomedical Challenges for Integrating Multi-view Data | 2 | 2025 |
| R50CA211462 | Critical Resources Provided by UNMC RAP Biorepository Stimulate Cancer Research | 2 | 2025 |
| T32AR007530 | Immunologic Mechanisms and Rheumatic Diseases | 2 | 2025 |
| T32DC009401 | University of Wisconsin Voice Research Training Program | 2 | 2025 |
| T32DE007057 | Tissue Engineering and Regeneration | 2 | 2025 |
| T32EY007145 | Training Program in the Molecular Bases of Eye Disease | 2 | 2025 |
| U42OD011158 | Research Resource for Human Organs and Tissues | 2 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4060/grants?page=5